Media

Bioscience industry a bright spot among the technology sector
The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the...

Press Releases

Jun 10 2002
Toronto (June 10, 2002) - Aventis, one of the world's leading pharmaceutical companies, is sponsoring the combined 2002 BioGENEius/Aventis Biotech Challenge to...
Jun 9 2002
Unless otherwise noted, all events are in the Metro Toronto Convention Centre. See note at the end for media registration guidelines, and visit the...
Jun 9 2002
Unless otherwise noted, all events are in the Metro Toronto Convention Centre. See note at the end for media registration guidelines, and visit the...
Jun 9 2002
Unless otherwise noted, all events are in the Metro Toronto Convention Centre. See note at the end for media registration guidelines, and visit the...
Jun 9 2002
Unless otherwise noted, all events are in the Metro Toronto Convention Centre. See note at the end for media registration guidelines, and visit the...
Jun 9 2002
TORONTO (June 9, 2002) - A panel of experts on agriculture the developing world will convene during the Biotechnology Information Organization (BIO) 2002...
Jun 8 2002
WASHINGTON, D.C. (June 9, 2002) - Tommy G. Thompson, secretary of the U.S. Department of Health and Human Services, is scheduled to speak at the Biotechnology...
Jun 7 2002
TORONTO (June 7, 2002) – The BIO 2002 press room opens tomorrow, Saturday, June 8 at the Metro Toronto Convention Centre. From today through Wednesday, June 12...
Jun 5 2002
Media is invited to attend the BIO 2002 Media Brunch featuring executives from five leading companies whose new biotechnology applications are creating...


Biotechnology News

July 22, 2014

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced top-line results from the ExteNET study of its investigational drug neratinib, a Phase III trial in adjuvant...

July 22, 2014

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced that its license agreement with Pfizer for the investigational drug neratinib (PB272) has been amended.

July 22, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Announces Proposed Underwritten Offering of Common Stock

July 22, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced today that the manuscript from its multi-center (n=20), randomized, controlled clinical...

July 22, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Reports Second Quarter 2014 Financial Results